You unfold the leaflet that came inside the medicine box. It is a single sheet of thin paper, folded seven times, printed on both sides in a font so small that you need to hold it at arm’s length — or give up and reach for reading glasses. The text runs for what feels like pages: warnings, side effects, chemical names, dosages for age groups you do not belong to, and paragraphs of legal language.

Most people refold the leaflet, put it back in the box, and never look at it again.

This is a problem, because the medicine leaflet is the single most complete source of information about any medicine you take. It is more detailed than what your doctor told you in a three-minute consultation, more accurate than the pharmacy assistant’s verbal summary, and more reliable than whatever you found in a search engine.

The trick is knowing which parts to read and which to skip.

PIL vs SmPC — Two Documents, Two Audiences

Every medicine approved in the EU has two official information documents. They contain largely the same information, but they are written for different readers.

PIL — Patient Information Leaflet

This is the folded sheet inside your medicine box. It is written in plain language (or at least, it attempts plain language) and is aimed at patients. EU regulations require that a PIL be tested on real people for readability before the medicine can be approved. The sections follow a standardised order so you can always find the same type of information in the same place, regardless of the medicine.

SmPC — Summary of Product Characteristics

This is the professional document intended for doctors and pharmacists. It contains the same clinical information as the PIL, plus additional detail: pharmacokinetic data, clinical trial results, detailed mechanism of action, and prescribing guidance that assumes medical training.

You do not normally receive the SmPC — it is not printed and included in the box. But it is publicly available for every EU-approved medicine through the national medicines agency’s website (in Poland, that is the Office for Registration of Medicinal Products at urpl.gov.pl) or the European Medicines Agency’s website for centrally authorised products.

When to read the SmPC instead of the PIL

For most everyday situations, the PIL is sufficient. But if you want deeper detail — for instance, understanding exactly how two medicines interact, or what the half-life of a drug is (which tells you how long it stays active in your body) — the SmPC provides answers that the PIL simplifies or omits.

The Key Sections of a PIL and What They Tell You

Every PIL follows the same six-section structure. Here is what each section contains and why it matters.

Section 1: What the medicine is and what it is used for

This section names the active substance (not the brand name — the actual chemical compound), describes its therapeutic class (e.g., “non-steroidal anti-inflammatory drug”), and lists the approved indications — the conditions it is licensed to treat.

Why it matters: The active substance name is what you need to check for duplicates. If you take two medicines with the same active substance without realising it, you are effectively doubling the dose. Paracetamol, for instance, is the active ingredient in dozens of branded products. Without checking, you could easily take Panadol and a “cold and flu” remedy that also contains paracetamol, exceeding the safe daily limit.

Section 2: What you need to know before you take it

This is the longest and most important section. It covers:

Contraindications (“Do not take this medicine if…”) — absolute reasons not to use it, such as allergy to the active substance, certain medical conditions, or pregnancy.
Warnings and precautions (“Talk to your doctor or pharmacist before taking…”) — situations where the medicine is not outright banned but requires caution, extra monitoring, or dose adjustment.
Other medicines and interactions (“Tell your doctor if you are taking…”) — a list of medicines, supplements, or even foods that interact with this one. This section is critical, but it is also where PILs become genuinely difficult to parse because the list can be long and full of unfamiliar drug names.
Pregnancy, breastfeeding, and fertility — what is known about safety during pregnancy and nursing.
Driving and using machines — whether the medicine affects alertness or reaction time.

Why it matters: This section tells you whether the medicine is safe for you specifically. A medicine that is perfectly safe for the general population might be dangerous for someone with a particular liver condition, or someone taking a specific blood thinner.

Section 3: How to take it

Dosage instructions, including different doses for adults, children (often by age and weight ranges), and elderly patients. It also explains what to do if you take too much, miss a dose, or stop taking the medicine suddenly.

Why it matters: “Take one tablet” is meaningless without knowing the strength. This section specifies exact milligram doses and maximum daily limits. For children’s medicines, it often includes weight-based dosing tables that are far more precise than the verbal advice you might receive.

Section 4: Possible side effects

The section most people either obsess over or deliberately avoid. Side effects are categorised by frequency: very common (more than 1 in 10 people), common (1 in 100), uncommon (1 in 1,000), rare (1 in 10,000), and very rare (fewer than 1 in 10,000).

Why it matters: Reading the frequency labels is crucial. Many people stop taking a medicine after reading the side effects list without noticing that the alarming ones occur in fewer than 1 in 10,000 patients. Conversely, “very common” side effects are ones you should genuinely expect and plan for.

The section also tells you which side effects require immediate medical attention — typically flagged with phrases like “stop taking and contact your doctor immediately.”

Section 5: How to store the medicine

Temperature limits (e.g., “do not store above 25 degrees Celsius”), light sensitivity (“keep in the original packaging”), humidity requirements, and — importantly — how long the medicine is safe to use after opening. Some liquid medicines, eye drops, and creams have a much shorter shelf life once opened than the printed expiry date on the box suggests.

Why it matters: A medicine stored incorrectly may lose potency or degrade well before its expiry date. An insulin pen left in a hot car, or eye drops kept for six months after opening, may no longer work — or may be actively harmful.

Section 6: Contents of the pack and other information

This lists the inactive ingredients (excipients), the physical appearance of the medicine, and the manufacturer’s details. For most people this section is skippable — unless you have known allergies to specific excipients like lactose, certain dyes, or gluten.

Quick-Find Tips for Reading Leaflets

You do not need to read the entire PIL every time. Here are the fastest paths to the information you usually need.

”Can I take this with my other medicine?”

Go directly to Section 2, the “Other medicines” subsection. Look for the name of your other medicine. If the list is long and you cannot find it, this is where a digital interaction checker adds real value — it cross-references databases far more comprehensive than any single leaflet.

”What is the dose for my child?”

Section 3. Look for a weight-based or age-based table. If the leaflet says “not recommended for children under 12” and your child is 11, do not improvise — call a pharmacist or doctor.

”I am pregnant — is this safe?”

Section 2, the “Pregnancy and breastfeeding” subsection. If the language is ambiguous (“should only be used if the potential benefit justifies the potential risk”), that is a conversation for your doctor, not a decision to make alone.

”Do I need to refrigerate this?”

Section 5. If it says “store below 8 degrees Celsius,” it belongs in the fridge. If it says “do not refrigerate,” keep it out. Some medicines, like certain liquid antibiotics, need refrigeration after reconstitution but not before.

”I missed a dose — what now?”

Section 3, toward the end. Most leaflets have explicit instructions for missed doses. The standard advice varies by medicine: some say take it as soon as you remember, some say skip to the next scheduled dose, and some have specific time cut-offs.

When the Leaflet Is Not Enough

Leaflets are comprehensive, but they have limitations. They cannot check interactions across your entire medicine collection. They cannot alert you that two of your medicines contain the same active substance under different brand names. And they cannot remind you to actually read them.

The leaflet access feature in mojApteczka links every medicine in your digital cabinet directly to its official PIL. You do not need to dig through the physical box or unfold a crumpled sheet — the leaflet is a tap away, displayed in a readable format on your screen.

For drug interactions specifically, the interaction checker goes beyond what any single leaflet can do. It cross-references every medicine in your cabinet against the DDInter 2.0 database, checking over 1.3 million known interaction pairs. The result is a severity-sorted list that shows you, at a glance, whether anything in your cabinet conflicts with anything else — across all family members, all medicines, all at once.

The Leaflet Deserves Five Minutes

You do not need to memorise the entire document. You do not need a medical degree to understand it. You need five minutes, focused on the sections that apply to your situation: the active ingredient (Section 1), the contraindications and interactions (Section 2), the dosage (Section 3), and the storage conditions (Section 5).

Those five minutes are among the most valuable you can spend on your health. The information is there — printed, regulated, tested for readability, and included in every single medicine box. All you have to do is unfold it.

Manage your leaflets digitally at mojapteczka.pl and make them easier to find, read, and act on. You can also download the Android app from Google Play.

Have questions about a specific medicine leaflet? Write to us at kontakt@mojapteczka.pl — we are happy to help.